Eton Pharmaceuticals Quarterly Cash Flow Statement
NASDAQ: ETONHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Eton Pharmaceuticals free cash flow
In the quarter ended Jun 30, 2026, Eton Pharmaceuticals generated $7.3 million of operating cash flow and spent $5,000 on capital expenditures. That left free cash flow of $7.3 million, a free-cash-flow margin of 19.3% of revenue. Free cash flow was down 8.8% from the prior year's $8.0 million.
Summary generated from market data by MetaCap's automated system. Methodology
Eton Pharmaceuticals cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 11.58M | 1.55M | 1.48M | -1.93M | -2.58M | -1.57M | -598.00K | 627.00K | -3.04M | -811.00K | -2.26M | -579.00K |
| Net Income growth (YoY) | — | — | — | -407.34% | — | — | — | — | -166.70% | — | -347.37% | — |
| Depreciation & Amortization | 1.39M | 1.13M | 1.02M | 1.01M | 1.00M | 1.01M | 355.00K | 278.00K | 279.00K | 234.00K | 325.00K | 191.00K |
| Stock-Based Compensation | 1.47M | 1.52M | 1.12M | 1.09M | 2.10M | 1.20M | 782.00K | 722.00K | 840.00K | 821.00K | 750.00K | 730.00K |
| Change in Working Capital | -6.02M | 2.48M | -4.63M | 10.88M | -4.29M | -8.38M | -1.75M | 380.00K | 244.00K | -3.38M | 1.03M | -1.85M |
| Operating Cash Flow | 7.25M | 7.41M | -11.55M | 12.03M | 7.96M | 2.09M | -765.00K | 2.95M | 1.25M | -2.47M | 387.00K | 873.00K |
| Capital Expenditures | 5.00K | -75.00K | -49.00K | -284.00K | 0 | 0 | -12.00K | 0 | 0 | -14.00K | 0 | 0 |
| Investing Cash Flow | 5.00K | -15.07M | -49.00K | -284.00K | 0 | 0 | -38.13M | 0 | 0 | -1.88M | -775.00K | 0 |
| Debt Repaid | — | — | 0 | 0 | 0 | 0 | 0 | -385.00K | -385.00K | -385.00K | -385.00K | -385.00K |
| Financing Cash Flow | -76.00K | 1.39M | 421.00K | 0 | 0 | 394.00K | 33.57M | -385.00K | -216.00K | -378.00K | -294.00K | -369.00K |
| Net Change in Cash | 7.18M | -6.28M | -11.18M | 11.74M | 7.96M | 2.48M | -5.33M | 2.57M | 1.04M | -4.73M | -682.00K | 504.00K |
| Free Cash Flow | 7.26M | 7.33M | -11.60M | 11.74M | 7.96M | 2.09M | -777.00K | 2.95M | 1.25M | -2.49M | 387.00K | 873.00K |
This table shows 12 quarterly periods of Eton Pharmaceuticals's cash flow statement, from Q2 2026 back to Q3 2023, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ETON's reporting calendar. What is a cash flow statement?